Physician profile
Emily E Roberts
NPI 1770730053
$7,560.36
in general payments reported to CMS, 2019-2025
32 companies · $1,784 in 2025
The $1,784 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $657 · 2022: $1,358 · 2023: $2,070 · 2024: $1,691 · 2025: $1,784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,159 · Education: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,159.44 |
| Education | $386.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,535.60 | 2021-2025 | |
| Janssen Biotech, INC. | $762.63 | 2021-2025 | Tremfya, Simponi Aria, Remicade |
| Sun Pharmaceutical Industries INC. | $552.12 | 2023-2025 | Ilumya, Odomzo, Blu-U |
| E.R. Squibb & Sons, L.L.C. | $443.27 | 2022-2024 | Sotyktu |
| Amgen INC. | $427.90 | 2021-2025 | Otezla, Otezla |
| Regeneron Healthcare Solutions, INC. | $373.39 | 2021-2025 | Dupixent |
| Incyte Corporation | $349.16 | 2022-2025 | Opzelura |
| Dermavant Sciences, INC. | $344.47 | 2023-2024 | Vtama |
| Leo Pharma INC. | $344.19 | 2021-2025 | Adbry |
| Lilly USA, LLC | $340.02 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Novartis Pharmaceuticals Corporation | $328.01 | 2021-2025 | |
| Ucb, INC. | $278.70 | 2022-2025 | Bimzelx, Cimzia |
| Genzyme Corporation | $239.62 | 2022-2025 | |
| Arcutis Biotherapeutics, INC. | $183.31 | 2023-2025 | Zoryve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $150.66 | 2023-2025 | Spevigo, Cyltezo |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $100.86 | 2021-2024 | Siliq |
| Organogenesis INC. | $96.05 | 2023-2025 | Puraply, Via Matrix, Cygnus Dual |
| Pfizer INC. | $89.86 | 2021-2025 | |
| Genentech USA, INC. | $79.85 | 2021-2024 | Erivedge |
| Fresenius Kabi USA, LLC | $79.00 | 2023-2024 | Idacio |
| Mimedx Group, INC. | $74.45 | 2024-2025 | |
| Kyowa Kirin, INC. | $72.89 | 2022-2025 | Poteligeo |
| Journey Medical Corporation | $61.91 | 2022-2023 | |
| Galderma Laboratories, L.P. | $61.65 | 2023-2025 | Aklief, Epsolay, Nemluvio |
| Almirall LLC | $53.64 | 2022-2023 | Seysara |
| Vyne Pharmaceuticals INC. | $40.16 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $20.31 | 2023 | |
| Biofrontera INC. | $18.33 | 2023 | Xepi, Bf-Rhodoled, Ameluz |
| Paratek Pharmaceuticals, INC. | $15.91 | 2021 | |
| Lnhc, INC | $15.69 | 2025 | Zelsuvmi |
| Helsinn Therapeutics (U.S.), INC. | $13.58 | 2023 | Valchlor |
| Janssen Pharmaceuticals, INC | $13.17 | 2025 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.